02/27/2013 | Press release

Geron to Present at the Cowen and Company Health Care Conference

distributed by noodls on 02/27/2013 09:01

Print Print

Sharing and Personal Tools

MENLO PARK, Calif., February 27, 2013 - Geron Corporation (Nasdaq: GERN) today announced that Olivia Bloom, Senior Vice President, Finance, and Chief Financial Officer, will present an overview of the company at 10:40 a.m. Eastern Time on Wednesday, March 6, at the Cowen and Company 33rd Annual Health Care Conference in Boston.

A live webcast of the presentation will be available at http://wsw.com/webcast/cowen10/gern/. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.

About Geron

Geron is a biopharmaceutical company developing first-in-class therapies for cancer, including its telomerase inhibitor, imetelstat, in clinical development. For more information about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com

###

HUG#1681254

Back

View original format